Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery.
Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trial.
Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified?
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
See All 41 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
Wu X, Zhang N, Lee MM. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation. Endocrinology. 2012 Oct; 153(10):4929-37.
View in:
PubMed
subject areas
Activin Receptors, Type I
Androstenedione
Animals
Anti-Mullerian Hormone
Bone Morphogenetic Protein Receptors, Type I
Cell Count
Cell Differentiation
Down-Regulation
Leydig Cells
Luteinizing Hormone
Male
Mice
Mice, Knockout
Phosphoproteins
Receptors, Peptide
Receptors, Transforming Growth Factor beta
Steroid 17-alpha-Hydroxylase
Testis
Testosterone
authors with profiles
Mary M Lee MD
Ning Zhang PhD